| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |